NCT01799876View on ClinicalTrials.gov

Use of Cell Therapy to Enhance Arthroscopic Knee Cartilage Surgery

NACompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

February 28, 2013

Primary Completion Date

August 31, 2016

Study Completion Date

August 31, 2017

Conditions
Articular Cartilage Defect Grade III or IV of the Knee
Interventions
PROCEDURE

Autologous Cell

PROCEDURE

Standard microfracture arthroscopic surgery

Trial Locations (1)

77030

Fondren Orthopedic Group, L.L.P., Houston

Sponsors

Collaborators (1)

InGeneron, Inc.
All Listed Sponsors
collaborator

InGeneron, Inc.

INDUSTRY

lead

Fondren Orthopedic Group L.L.P.

OTHER